Press release
United States Visceral Leishmaniasis Treatment Market 2025 | Growth Drivers, Key Players & Investment Opportunities
Visceral Leishmaniasis Treatment Market
Global visceral leishmaniasis treatment market is expected to reach at a high CAGR during the forecast period 2024-2031.
Key Development:
United States: Recent Industry Developments
✅ In May 2025, the World Health Organization (WHO) launched a comprehensive framework to guide health authorities towards the elimination of Visceral Leishmaniasis (VL) as a public health problem in Eastern Africa.
✅ In February 2025, Novartis and DNDi advanced the Phase II clinical trials for LXE408, an oral treatment for VL, enrolling patients in India and Ethiopia.
✅ In January 2025, the Global Health Innovative Technology (GHIT) Fund announced a total investment of approximately USD 12.7 million in eight projects, including diagnostics and drug development for neglected tropical diseases (NTDs) and malaria.
Japan: Recent Industry Developments
✅ In August 2025, Japan's commitment to global health innovation was highlighted at the Tokyo International Conference on African Development (TICAD), focusing on combination therapies for leishmaniasis and the development of new compounds for Chagas' disease.
✅ In April 2025, Japan's Ministry of Health, Labour and Welfare invested an additional USD 1 million to support the Global Antibiotic Research and Development Partnership (GARDP), bringing total investment to USD 10 million since 2020, to develop new treatments for drug-resistant infections.
✅ In March 2025, the GHIT Fund announced a USD 4.2 million investment in a project led by Ohio State University in collaboration with Nagasaki University and icddr,b to refine formulations of the leishmanin antigen and prepare for clinical trials, aiming to strengthen efforts to monitor infection status and eliminate VL.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/visceral-leishmaniasis-treatment-market?sb
Key Players:
=> Merck KGaA, PRG Pharma, LEXICARE PHARMA PVT. LTD., SanMak Pharmaceuticals Private Limited, Pfizer Inc., Avet Pharmaceuticals Inc., Profounda Pharmaceuticals,Knight Therapeutics Inc., Sun Pharmaceutical Industries Ltd. and Gilead Sciences, Inc..
Growth Forecast Projected:
The Global Visceral Leishmaniasis Treatment Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Visceral Leishmaniasis Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=visceral-leishmaniasis-treatment-market
Key Segments:
➥ By Drug Type: Pentavalent Antimonials (Sodium Stibogluconate (Pentostam), Meglumine Antimoniate (Glucantim)), Antimicrobials (Paromomycin, Miltefosine), Antifungal (Amphotericin B Liposomal)
➥ By Route of Administration: Oral, Intravenous, Others
➥ By End User: Hospitals, Ambulatory Surgical Centers, Others
Regional Analysis for Visceral Leishmaniasis Treatment Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.
Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.
Chapter 3: Offers an in-depth look at the competitive landscape among Visceral Leishmaniasis Treatment producers, including revenue shares, strategic moves, and recent mergers and acquisitions.
Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.
Chapters 5 & 6: Analyze Visceral Leishmaniasis Treatment revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.
Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.
Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.
Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.
Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/visceral-leishmaniasis-treatment-market?sb
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Visceral Leishmaniasis Treatment Market 2025 | Growth Drivers, Key Players & Investment Opportunities here
News-ID: 4208555 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Polyamide Market 2025 | Growth Drivers, Trends & Market Forecast, …
Market Size and Growth
The Global Polyamide Market reached USD 37.4 billion in 2022 and is expected to reach USD 60.2 billion by 2031, growing with a CAGR of 6.2% during the forecast period 2024-2031.
Key Development:
Polyamide Industry: Recent Developments
United States:
✅ October 2, 2025 - At K 2025, BASF presented two pioneering technologies for recycling polyamides from end-of-life vehicles, aiming to reduce plastic waste and promote circular economy practices.
✅ September 9, 2025…
Autonomous Data Platform Market to Reach USD 14.96 Billion by 2032, Report by Da …
Overview of the Autonomous Data Platform Market
The Autonomous Data Platform (ADP) market is witnessing rapid growth, driven by digital transformation and the increasing need for real-time data analytics. ADPs use Artificial Intelligence (AI) and Machine Learning (ML) to automate data management, enabling businesses to make faster, data-driven decisions while minimizing human intervention. These platforms enhance operational efficiency, reduce errors, and allow enterprises to focus on strategic initiatives. ADPs are increasingly…
Global 6G Technology Market to Reach USD 9.03 Billion by 2032, Report by DataM I …
Overview of the Global 6G Technology Market
The 6G technology market represents the next frontier in wireless communication, promising unprecedented advancements in speed, connectivity, and intelligence. Building upon the foundation laid by 5G, 6G aims to deliver peak data rates exceeding 1 terabit per second, ultra-low latency, and seamless integration of artificial intelligence (AI) and quantum-resistant encryption. These capabilities are set to revolutionize industries such as healthcare, automotive, manufacturing, and entertainment…
Spinal Muscular Atrophy Treatment Market to Reach USD 20.06 Billion by 2033, Rep …
Overview of the Spinal Muscular Atrophy Treatment Market
Spinal Muscular Atrophy (SMA) is a rare genetic disorder characterized by progressive muscle weakness, leading to severe physical disability and, in many cases, early death. The advent of innovative therapies has significantly altered the treatment landscape for SMA, offering hope for improved patient outcomes. Gene therapies, such as onasemnogene abeparvovec (Zolgensma), nusinersen (Spinraza), and risdiplam (Evrysdi), have demonstrated efficacy in increasing survival rates…
More Releases for Visceral
Visceral Leishmaniasis Market Generated Opportunities, Future Scope 2025-2032
The most recent report published by WMR indicates that the "Visceral Leishmaniasis Market" is likely to accelerate significantly in the next few years. The Visceral Leishmaniasis Market report gives a purposeful depiction of the area by the practice for research, amalgamation, market size, overview, and review of data taken from various sources. The Visceral Leishmaniasis Market study includes information on market factors such as the market dynamics, drivers, restraints, challenges,…
Innovative NHE3 Inhibitor Advances Visceral Pain Treatment Industry Trends Gaini …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Visceral Pain Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for visceral pain has seen a significant rise in the past few years. The prediction is that it will increase from $13.84 billion in 2024 to $14.87 billion in 2025, with a…
Notable Surge In Buprenorphine Prescriptions Propels Visceral Pain Market Expans …
The Visceral Pain Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Visceral Pain Market Size During the Forecast Period?
There has been a significant expansion in the size of the visceral pain market in past years. The market is projected to increase…
Visceral Leishmaniasis Market Share, Size, Trends and Global Forecast
The Visceral Leishmaniasis Treatments Market Is Set To Grow At An Estimated CAGR Of 6.6% From 2025 To 2034, Rising From $580 Million In 2024 To $1.1 Billion By 2034.
On April 15, 2025, Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Visceral Leishmaniasis market goods. The market study excludes key regions that are accelerating marketization. This…
Key Influencer in the Visceral Pain Market 2025: Notable Surge In Buprenorphine …
What market dynamics are playing a key role in accelerating the growth of the visceral pain market?
The visceral pain market's growth is anticipated to be powered by an increasing need for analgesics. These pain relievers work by reducing or inhibiting the brain's perception of pain signals, providing relief from visceral pain by affecting the nervous system and controlling pain signals from the internal organs. The New England Journal of Medicine,…
Notable Surge In Buprenorphine Prescriptions Propels Visceral Pain Market Expans …
What Are the Projections for the Size and Growth Rate of the Visceral Pain Market?
Over the past few years, significant expansion has occurred in the visceral pain market. The projection is for it to escalate from a value of $13.84 billion in 2024 to a value of $14.87 billion in 2025, a compound annual growth rate (CAGR) of 7.5%. The surge during the historical growth cycle has been driven by…
